NEW York (GenomeWeb News) – Gen-Probe and 3M said after the close of the market on Monday that they have disbanded their collaboration to develop molecular diagnostic tests for healthcare-associated infections.
 
The firms had been evaluating whether they could combine Gen-Probe’s nucleic acid testing technologies with 3M’s microfluidics instrument platform but found the technologies to be technically incompatible.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.